Tag: VIVID

Improving efficacy with longer mirikizumab treatment in CD

Presented By
Prof. Séverine Vermeire, KU Leuven, Belgium
Trial
Phase 3, VIVID-2
Conference
ECCO 2025
Type
Peer-reviewed article

8 April 2025 10:39

Sustained efficacy of mirikizumab in moderate-to-severe Crohn’s disease

Principal Investigator
Prof. Bruce E. Sands, Icahn School of Medicine at Mount Sinai, NY, USA
Trial
Phase 2, SERENITY
Conference
UEGW 2020
Type
News article

2 November 2020 12:20
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com